randomized double-blind placebo-controlled trial of acetyl-l-carnitine for als A 1-year multicenter study in patients with Alzheimer's disease Pharmacometabolomics applied to low‐dose interleukin‐2

Pharmacometabolomics applied to lowdose interleukin2 treatment in amyotrophic lateral sclerosis Alarcan 2024 Annals of the New York Academy of Sciences Wiley Online Library A randomized double blind placebo controlled clinical trial of nitazoxanide for treatment of mild or moderate COVID 19 ScienceDirect A multicenter, randomized, placebo controlled, double blind phase 3 trial with open arm comparison indicates safety and efficacy of nephroprotective therapy with ramipril in children with Alport's syndrome Kidney International Efficacy and safety of low dose IL 2 as an add on therapy to riluzole (MIROCALS): a phase 2b, double blind, randomised, placebo controlled trial The Lancet

SKU: 93529610025 · From webdevsolutions.tech